Aptevo Therapeutics Inc (APVO) — Cash Flow Quality Index
Aptevo Therapeutics Inc (APVO) has a Cash Flow Quality Index of 1.65x as of March 2023. Operating cash flow of $4.57 Million exceeds net income of $2.77 Million, indicating high earnings quality where cash backs reported profits. Explore Aptevo Therapeutics Inc (APVO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aptevo Therapeutics Inc Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Aptevo Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see APVO cash flow conversion.
Annual Cash Flow Quality Index for Aptevo Therapeutics Inc (2017–2022)
Year-by-year earnings quality comparison for Aptevo Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.62x | $-21.02 Million | $8.03 Million | ▲ +56.1% |
| 2017 | -5.96x | $-41.57 Million | $6.97 Million | — |